Harnessing Agile and Cross-Functional Project Management to Compress Drug Development Cycles in the Biopharma Sector – The Role of Traditional Project Planning and Scheduling
Journal of Science Technology and Social Transformation · 18.07.2025 · 1 (02)
DOI: 10.64235/sm569s90 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Science Technology and Social Transformation, online erschienen am 18.07.2025. Verfasst von Oba und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
The biopharmaceutical industry faces increasing pressure to accelerate drug development while maintaining regulatorycompliance and ensuring product safety. Traditional project management approaches, while foundational in ensuringlong-term scheduling and regulatory oversight, often lack the flexibility required to respond to dynamic market demandsand scientific uncertainty. This study explores the integration of agile methodologies and cross-functional team structuresas a strategic response to compress development cycles in the biopharma sector. Drawing on recent empirical studies andindustry case analyses, the article investigates how agile frameworks, when layered onto or hybridized with traditionalplanning models, can enhance responsiveness, improve interdepartmental coordination, and reduce decision-makingbottlenecks. Furthermore, the research examines the role of data visualization tools, digital platforms, and innovationsourcing in optimizing project flow across dispersed and interdisciplinary teams. While agile transformation offers substantialpromise, challenges such as cultural inertia, regulatory alignment, and leadership capability persist. The findings suggestthat hybrid project ecosystems anchored in traditional scheduling but empowered by agile practices and digital enablerscan deliver faster, more adaptive, and value-driven drug development outcomes. This paper contributes to ongoingdebates around project governance in complex, high-stakes innovation environments and offers practical guidance foroperational leaders, R&D managers, and transformation strategists in life sciences.
Zitieren
APA
Oba, & Taiwo, T. (2025). Harnessing Agile and Cross-Functional Project Management to Compress Drug Development Cycles in the Biopharma Sector – The Role of Traditional Project Planning and Scheduling. Journal of Science Technology and Social Transformation, 1(02). https://doi.org/10.64235/sm569s90
Vancouver
Oba, Taiwo T. Harnessing Agile and Cross-Functional Project Management to Compress Drug Development Cycles in the Biopharma Sector – The Role of Traditional Project Planning and Scheduling. Journal of Science Technology and Social Transformation. 2025;1(02). doi:10.64235/sm569s90
BibTeX
@article{Oba2025,
author = {Oba and Taiwo, Timothy},
title = {Harnessing Agile and Cross-Functional Project Management to Compress Drug Development Cycles in the Biopharma Sector – The Role of Traditional Project Planning and Scheduling},
journal = {Journal of Science Technology and Social Transformation},
year = {2025},
volume = {1},
number = {02},
doi = {10.64235/sm569s90}
}
EUVIMED